Varian cancer treatment system cleared in US:
This article was originally published in Clinica
Executive Summary
VariSource, Varian Associates' high dose rate remote afterloader cancer treatment system, has been given 510(k) clearance for marketing in the US. Frequently used in the treatment of gynaecological and lung cancers, the system employs a catheter and applicators to position a radioactive isotope directly in or next to tumour sites. It is used to administer most treatments on an outpatient basis and can be used to supplement conventional external beam radiotherapy and certain surgical procedures. VariSource is produced at Varian's factory in Crawley in the UK.